ATE311463T1 - Fusionsprotein mit multiplen epitopen - Google Patents

Fusionsprotein mit multiplen epitopen

Info

Publication number
ATE311463T1
ATE311463T1 AT97927767T AT97927767T ATE311463T1 AT E311463 T1 ATE311463 T1 AT E311463T1 AT 97927767 T AT97927767 T AT 97927767T AT 97927767 T AT97927767 T AT 97927767T AT E311463 T1 ATE311463 T1 AT E311463T1
Authority
AT
Austria
Prior art keywords
epitopes
epitope
amino acid
acid sequence
sequences
Prior art date
Application number
AT97927767T
Other languages
German (de)
English (en)
Inventor
Pablo D T Valenzuela
David Ying Chien
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/653,226 external-priority patent/US6514731B1/en
Application filed by Chiron Corp filed Critical Chiron Corp
Application granted granted Critical
Publication of ATE311463T1 publication Critical patent/ATE311463T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT97927767T 1996-05-24 1997-05-23 Fusionsprotein mit multiplen epitopen ATE311463T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/653,226 US6514731B1 (en) 1996-05-24 1996-05-24 Methods for the preparation of hepatitis C virus multiple copy epitope fusion antigens
US08/859,524 US6428792B1 (en) 1996-05-24 1997-05-20 Hepatitis C virus multiple copy epitope fusion antigens
PCT/US1997/008950 WO1997044469A2 (en) 1996-05-24 1997-05-23 Multiple epitope fusion protein

Publications (1)

Publication Number Publication Date
ATE311463T1 true ATE311463T1 (de) 2005-12-15

Family

ID=27096474

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97927767T ATE311463T1 (de) 1996-05-24 1997-05-23 Fusionsprotein mit multiplen epitopen

Country Status (11)

Country Link
EP (1) EP0935662B1 (ja)
JP (2) JP3945822B2 (ja)
AT (1) ATE311463T1 (ja)
AU (1) AU719929B2 (ja)
CA (1) CA2250723C (ja)
DE (1) DE69734776T2 (ja)
DK (1) DK0935662T3 (ja)
ES (1) ES2251028T3 (ja)
IL (1) IL126460A (ja)
NZ (1) NZ333431A (ja)
WO (1) WO1997044469A2 (ja)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0870830A3 (en) * 1997-02-10 2004-02-25 Advanced Life Science Institute, Inc. Chimera hepatitis C virus antigen
AU9497998A (en) * 1997-09-22 1999-04-12 Chiron Corporation Method for detecting antibodies in a sample
EP1021723B1 (en) 1997-09-22 2008-12-10 Novartis Vaccines and Diagnostics, Inc. Buffers for stabilizing hcv antigens
EP1056762A4 (en) * 1998-01-30 2003-07-23 Gen Hospital Corp GENETIC IMMUNIZATION WITH NON-STRUCTURAL PROTEINS OF HEPATITIS C VIRUS
TR200003024T2 (tr) 1998-04-17 2000-12-21 Innogenetics N.V. İndirgeme ajanlarını kullanarak geliştirilen immünodiagnostik tahliller.
AU3714499A (en) * 1998-05-14 1999-11-29 Pasteur Merieux Serums Et Vaccins Hepatitis c virus mimotopes
US7052696B2 (en) * 1998-07-10 2006-05-30 The United States Of America As Represented By The Department Of Health And Human Services Antigenic epitopes and mosaic polypeptides of hepatitis C virus proteins
US6379903B1 (en) * 1999-10-08 2002-04-30 Sigma-Aldrich Co. Purification of recombinant proteins fused to multiple epitopes
US6562346B1 (en) 1999-10-27 2003-05-13 Chiron Corporation Activation of HCV-specific T cells
BR0017052B1 (pt) * 1999-12-28 2013-12-24 Epimmune Inc Método para a projeção de um constructo poliepitópico e constructo poliepitópico preparado pelo referido método
EP1829891B1 (en) 2000-06-15 2012-12-26 Novartis Vaccines and Diagnostics, Inc. Immunoassays for Anti-HCV Antibodies
EP1350105B1 (en) 2000-06-15 2007-07-25 Novartis Vaccines and Diagnostics, Inc. Immunoassays for anti-hcv antibodies
US7491808B2 (en) 2000-06-15 2009-02-17 Novartis Vaccines And Diagnostics, Inc. HCV non-structural protein mutants and uses thereof
WO2003008537A2 (en) * 2001-04-06 2003-01-30 Mannkind Corporation Epitope sequences
AR045702A1 (es) 2001-10-03 2005-11-09 Chiron Corp Composiciones de adyuvantes.
NZ538711A (en) 2002-09-09 2007-01-26 Chiron Corp Antigen/antibody/antigen sandwich assays for detecting hepatitis C virus infections
AU2003287188A1 (en) * 2002-10-25 2004-05-25 Chiron Corporation Activation of hcv-specific cells
US7731967B2 (en) 2003-04-30 2010-06-08 Novartis Vaccines And Diagnostics, Inc. Compositions for inducing immune responses
JP4836281B2 (ja) 2004-08-27 2011-12-14 ノバルティス ヴァクシンズ アンド ダイアグノスティクス インコーポレイテッド Ｈｃｖ非構造タンパク質変異体およびその使用
ES2948791T3 (es) * 2005-06-17 2023-09-19 Msd Italia Srl Vacuna de ácido nucleico contra el virus de la hepatitis C
EP2360175B1 (en) 2005-11-22 2014-07-16 Novartis Vaccines and Diagnostics, Inc. Norovirus and Sapovirus virus-like particles (VLPs)
US8815253B2 (en) 2007-12-07 2014-08-26 Novartis Ag Compositions for inducing immune responses
CN103282375B (zh) 2010-12-02 2017-01-11 比奥诺尔免疫有限公司 肽支架设计
MX346475B (es) 2011-01-06 2017-03-22 Bionor Immuno As Peptidos inmunogenicos monomericos y multimericos.
CN104203272A (zh) * 2012-01-26 2014-12-10 长角牛疫苗和诊断有限责任公司 复合抗原序列及疫苗
MX2014014683A (es) 2012-06-06 2015-02-24 Bionor Immuno As Peptidos derivados de proteinas virales para usarse como inmunogenos y reactivos de dosificacion.
US11867696B2 (en) 2015-02-06 2024-01-09 Cell Idx, Inc. Antigen-coupled immunoreagents
DK3274478T3 (da) 2015-03-27 2020-11-23 Ortho Clinical Diagnostics K K Hcv-ns4a/modificerede ns3-polypeptider og anvendelser deraf
WO2018017606A1 (en) * 2016-07-18 2018-01-25 Cell Idx, Inc. Antigen-coupled hybridization reagents
KR101813586B1 (ko) * 2016-12-29 2018-01-30 고려대학교 산학협력단 다양한 질병마커 인지 에피토프와 연결된 단백질 나노입자 및 이를 이용한 고민감도 질병마커 검출방법
JP7389740B2 (ja) * 2017-07-27 2023-11-30 エフ． ホフマン－ラ ロシュ アーゲー Ｈｃｖ抗原のマルチエピトープ融合タンパク質およびその使用
KR101871985B1 (ko) * 2017-08-14 2018-06-27 고려대학교 산학협력단 3차원 단백질 나노입자 프로브 기반 복수 질환의 동시검출 방법 및 키트
CN108794636B (zh) * 2018-06-28 2020-05-22 中国人民解放军军事科学院军事医学研究院 一种表位多肽串联混合物在抗立氏立克次体的免疫保护中的应用
KR102100813B1 (ko) * 2018-11-08 2020-04-16 주식회사 보레다바이오텍 C형 간염바이러스 유래 융합 단백질 및 이를 포함하는 진단키트

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA40572C2 (uk) * 1991-06-24 2001-08-15 Чірон Корпорейшн Поліпептид, що містить укорочену послідовність вірусу гепатиту с, ізольований епітоп, реагент для імуноаналізу на вірус гепатиту с (варіанти), спосіб виявлення наявності антитіл (варіанти)
PT100978B (pt) * 1991-10-16 1999-10-29 Immulogic Pharma Corp Peptidos recombitope, sequencias de acidos nucleicos que os codificam, composicoes terapeuticas que os contem, processo para a sua concepcao e sue uso.
US5683695A (en) * 1993-02-10 1997-11-04 United Biomedical, Inc. Production of recombinant proteins containing multiple antigenic determinants linked by flexible hinge domains
US5744144A (en) * 1993-07-30 1998-04-28 University Of Pittsburgh University Patent Committee Policy And Procedures Synthetic multiple tandem repeat mucin and mucin-like peptides, and uses thereof
GB2294047A (en) * 1994-10-14 1996-04-17 Merck & Co Inc Synthetic peptides for use as epitopes specific for HIV

Also Published As

Publication number Publication date
DE69734776D1 (de) 2006-02-09
WO1997044469A3 (en) 1997-12-31
WO1997044469A8 (en) 1999-07-22
CA2250723C (en) 2012-07-17
JP2007127671A (ja) 2007-05-24
WO1997044469A2 (en) 1997-11-27
EP0935662B1 (en) 2005-11-30
IL126460A0 (en) 1999-08-17
DK0935662T3 (da) 2006-03-06
ES2251028T3 (es) 2006-04-16
IL126460A (en) 2007-07-04
AU3214397A (en) 1997-12-09
AU719929B2 (en) 2000-05-18
NZ333431A (en) 2000-05-26
DE69734776T2 (de) 2006-08-17
JP2001500723A (ja) 2001-01-23
JP3945822B2 (ja) 2007-07-18
CA2250723A1 (en) 1997-11-27
EP0935662A2 (en) 1999-08-18

Similar Documents

Publication Publication Date Title
ATE311463T1 (de) Fusionsprotein mit multiplen epitopen
CY1118443T1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοι και χρησεις
KR102061257B1 (ko) 단일 분자 검출을 이용한 분자 분석물질의 디지털 분석
HUP0100094A1 (hu) Új felületi antigén
DK2230299T3 (da) Hidtil ukendt cytokin ZCYTOR17-ligand
HUP0002488A2 (hu) Polietilénimin-alapú biomolekula-mátrixok
DE68929329T2 (de) CD 19 Kodierende DNA
FI961251A (fi) Ihmisten metabotrooppiset glutamaattireseptorialatyypit(HMR4, HMR6, HMR7)ja niihin liittyvät DNA-yhdisteet
JP5753775B2 (ja) 化学合成した核酸の純度を測定する方法と組成物
DE69738749D1 (de) Zelloberflächen-antigen aus säugetieren und verwandte reagenzien
NO315163B1 (no) Immunologisk aktive peptider, DNA-sekvenser som koder for peptidene og anvendelse av disse i et testsett for påvisning av virus somforårsaker immunsvikt
ATE399861T1 (de) Oberflächenantigene aus säugern
DE69230812D1 (de) Verfahren zum Nachweis einer Rinderdiarrhoe- virusinfektion, für ein durch eine Infektion mit diesem Virus induziertes Eiweiss kodierende Nukleotidsequenz, sowie daraus abgeleitete rekombinante Eiweisse und Antigene
WO1999009179A3 (en) Antigen constructs useful in the detection and differentiation of antibodies to hiv
Hovanec et al. Antigenic structure of the hemagglutinin of influenza virus B/Hong Kong/8/73 as determined from gene sequence analysis of variants selected with monoclonal antibodies
ATE162550T1 (de) Ospc-antigen-impfstoffe immunogene zusammensetzung zur vorbeugung und behandlung von lyme-krankheit und rekombinante verfahren zur herstellung von derartige antigene
Sledge et al. Antibody structure: amino terminal sequences of nurse shark light and heavy chains
DK0580672T3 (da) Syntetisk CDw52-(CAMPATH-1)-peptidantigen
DE3686452D1 (de) Aktiviertes bacillus thuringiensis-delta-endotoxin, hergestellt von einem manipulierten hybrid-gen.
DE69025023T2 (de) Peptide und deren Benutzung
DK0773999T3 (da) OR-1, en orphan-receptor tilhørende kernereceptorfamilien
Ferguson et al. Use of cluster analysis with monoclonal antibodies for taxonomic differentiation of phytopathogenic fungi and for screening and clustering antibodies
DE3569161D1 (en) Process for assaying atl virus antibody and reagent therefore
SU676303A1 (ru) Способ разделени углеводородных газов
EP0949333A4 (en) MUTANT ANTIGENS OF MEASURE VIRUS AND GENES ENCODING THEM

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0935662

Country of ref document: EP